ZA201000609B - Homogeneous vaccine composition for the tumor treatment and its obtaining method - Google Patents

Homogeneous vaccine composition for the tumor treatment and its obtaining method

Info

Publication number
ZA201000609B
ZA201000609B ZA201000609A ZA201000609A ZA201000609B ZA 201000609 B ZA201000609 B ZA 201000609B ZA 201000609 A ZA201000609 A ZA 201000609A ZA 201000609 A ZA201000609 A ZA 201000609A ZA 201000609 B ZA201000609 B ZA 201000609B
Authority
ZA
South Africa
Prior art keywords
vaccine composition
tumor treatment
obtaining method
homogeneous
homogeneous vaccine
Prior art date
Application number
ZA201000609A
Other languages
English (en)
Inventor
Martinez Gryssell Maria Rodrigues
Rodriguez Lisel Vina
Gonzalez Loany Calvo
Fiallo Ariadna Cuevas
Veliz Ernesto Chico
Ramos Tania Crombet
Novo Airama Albisa
Marinello Gisela Maria Gonzalez
Davila Agustin Bienvenido Lage
Original Assignee
Ct De Immunologia Molecular
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40225717&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA201000609(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ct De Immunologia Molecular filed Critical Ct De Immunologia Molecular
Publication of ZA201000609B publication Critical patent/ZA201000609B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/00113—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
ZA201000609A 2007-06-29 2010-01-27 Homogeneous vaccine composition for the tumor treatment and its obtaining method ZA201000609B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20070154A CU23652A1 (es) 2007-06-29 2007-06-29 Composición vacunal homogénea para el tratamiento del cáncer y su método de obtención

Publications (1)

Publication Number Publication Date
ZA201000609B true ZA201000609B (en) 2010-10-27

Family

ID=40225717

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA201000609A ZA201000609B (en) 2007-06-29 2010-01-27 Homogeneous vaccine composition for the tumor treatment and its obtaining method

Country Status (31)

Country Link
US (2) US8778879B2 (xx)
EP (1) EP2184072B1 (xx)
JP (1) JP5368437B2 (xx)
KR (1) KR20100039372A (xx)
CN (1) CN101790383B (xx)
AR (1) AR067085A1 (xx)
AT (1) ATE536885T1 (xx)
AU (1) AU2008271798B2 (xx)
BR (1) BRPI0813662B8 (xx)
CA (1) CA2692340C (xx)
CL (1) CL2008001936A1 (xx)
CO (1) CO6251274A2 (xx)
CU (1) CU23652A1 (xx)
CY (1) CY1112476T1 (xx)
DK (1) DK2184072T3 (xx)
EA (1) EA021905B1 (xx)
ES (1) ES2379130T3 (xx)
HK (1) HK1145979A1 (xx)
HR (1) HRP20120218T1 (xx)
JO (1) JO2777B1 (xx)
MY (1) MY149136A (xx)
NZ (1) NZ582829A (xx)
PE (2) PE20131037A1 (xx)
PL (1) PL2184072T3 (xx)
PT (1) PT2184072E (xx)
RS (1) RS52196B (xx)
SI (1) SI2184072T1 (xx)
TW (1) TWI409080B (xx)
UY (1) UY31184A1 (xx)
WO (1) WO2009003425A1 (xx)
ZA (1) ZA201000609B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU20200032A7 (es) * 2020-06-09 2022-01-13 Ct Inmunologia Molecular Composiciones vacunales basadas en nano-partículas de fosfatos de calcio para el tratamiento del cáncer
CN114594257B (zh) * 2022-05-09 2022-08-05 北京生物制品研究所有限责任公司 含CpG ODN的吸附型疫苗的解吸附组合物及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2261433A1 (en) * 1993-12-09 1995-06-10 Belinda Sanchez Ramirez Composition comprising autologous epidermal growth factor
CA2137639C (en) 1993-12-09 1999-01-26 Agustin B. L. Davila Vaccine composition comprising autologous epidermal growth factor or a fragment or a derivate thereof having anti-tumor activity and use thereof in the therapy of malignant diseases
CU23077A1 (es) * 2000-12-06 2005-08-17 Centro Inmunologia Molecular Composicion vacunal que contiene factor de crecimiento transformante (tgf-alfa). su uso en la terapia de enfermedades malignas
CU22979A1 (es) * 2000-12-08 2004-09-09 Centro Inmunologia Molecular Combinación inmunoterapéutica para el tratamiento de tumores que sobre-expresan receptores con actividad quinasa en residuos de tirosina
CU22999A1 (es) * 2001-12-04 2004-10-12 Centro Inmunologia Molecular Método de tratamiento de enfermedades malignas e infecciosas crónicas
GB0109297D0 (en) * 2001-04-12 2001-05-30 Glaxosmithkline Biolog Sa Vaccine
FR2844514B1 (fr) * 2002-09-16 2007-10-19 Neovacs Produit immunogene stable comprenant des heterocomplexes antigeniques, compositions les contenant et procede de preparation
GB0405787D0 (en) * 2004-03-15 2004-04-21 Chiron Srl Low dose vaccines

Also Published As

Publication number Publication date
EP2184072A1 (en) 2010-05-12
CO6251274A2 (es) 2011-02-21
EP2184072A4 (en) 2010-09-15
PE20090426A1 (es) 2009-05-05
RS52196B (en) 2012-10-31
CN101790383A (zh) 2010-07-28
US8841251B2 (en) 2014-09-23
TW200918092A (en) 2009-05-01
BRPI0813662B8 (pt) 2021-05-25
EP2184072B1 (en) 2011-12-14
AU2008271798A1 (en) 2009-01-08
AR067085A1 (es) 2009-09-30
PT2184072E (pt) 2012-03-21
CA2692340A1 (en) 2009-01-08
BRPI0813662A2 (pt) 2014-12-30
CN101790383B (zh) 2013-05-29
ATE536885T1 (de) 2011-12-15
PE20131037A1 (es) 2013-10-07
WO2009003425A1 (es) 2009-01-08
US20130039940A1 (en) 2013-02-14
DK2184072T3 (da) 2012-04-02
JO2777B1 (en) 2014-03-15
PL2184072T3 (pl) 2012-05-31
US8778879B2 (en) 2014-07-15
SI2184072T1 (sl) 2012-04-30
JP5368437B2 (ja) 2013-12-18
CL2008001936A1 (es) 2009-09-25
JP2010531817A (ja) 2010-09-30
CA2692340C (en) 2015-11-17
BRPI0813662B1 (pt) 2019-05-14
AU2008271798B2 (en) 2012-06-07
US20100196412A1 (en) 2010-08-05
TWI409080B (zh) 2013-09-21
EA201070080A1 (ru) 2010-12-30
HRP20120218T1 (hr) 2012-04-30
KR20100039372A (ko) 2010-04-15
CY1112476T1 (el) 2015-12-09
NZ582829A (en) 2012-03-30
UY31184A1 (es) 2009-01-05
CU23652A1 (es) 2011-05-27
HK1145979A1 (en) 2011-05-13
ES2379130T3 (es) 2012-04-23
MY149136A (en) 2013-07-15
EA021905B1 (ru) 2015-09-30

Similar Documents

Publication Publication Date Title
HRP20160949T1 (hr) Novi sastavi i metode za liječenje karcinoma
GB0700560D0 (en) Device and method for the treatment of diseased tissue such as tumours
IL213070A0 (en) Methods for the treatment of infections and tumors
HK1159498A1 (en) Methods and compositions for the treatment of cancer
EP2212440A4 (en) METHOD AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF ADENOCARCINOMES OF DISHES
EP2146632A4 (en) COMPOSITIONS AND METHODS FOR CELLULAR IMAGE PRESENTATION AND THERAPY
EP2340027A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
GB0604471D0 (en) Device and method for the treatment of tumours
IL196843A0 (en) Compositions and methods for the treatment of radiation proctosigmoitis
EP2231185A4 (en) METHOD AND COMPOSITIONS FOR TREATING LIQUID TUMORS
EP2049151A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF CANCER
EP2376089A4 (en) CANCER VACCINE COMPOSITIONS AND THEIR METHODS OF USE
EP2340851A4 (en) DIAGNOSTIC METHOD AND THERAPEUTIC METHOD FOR CANCER
ZA201003425B (en) 5-cyano-thienopyridines for the treatment of tumors
IL238394A0 (en) Cancer treatment method
EP2310021A4 (en) METHODS OF USING COMPOSITIONS COMPRISING MIR-192 AND / OR MIR-215 FOR THE TREATMENT OF CANCER
EP2150270A4 (en) METHODS AND COMPOSITIONS FOR TREATING CANCER
EP2198041A4 (en) METHOD AND COMPOSITION FOR CANCER DIAGNOSIS AND TREATMENT
EP2142566A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF PROLIFERATIVE DISEASES
EP2127697A4 (en) DYNAMIC TUMOR IRRADIATION TREATMENT APPARATUS AND DYNAMIC TUMOR IRRADIATION TREATMENT PROGRAM
ZA201000609B (en) Homogeneous vaccine composition for the tumor treatment and its obtaining method
ZA201009066B (en) Materials and methods for suppressing and/or treating neurofibroma and related tumors
HK1209754A1 (en) Compounds and methods for the treatment of cancer
EP2348865A4 (en) BETA-HYDROXY-GAMMA-AMINOPHOSPHONATES, THEIR METHODS OF PREPARATION AND THEIR USE
GB0808326D0 (en) Compositions and methods for the treatment of fybromyalgia